• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Quality of life assisted reproduction Cover
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Read more
© Mayer Tawfik/Unsplash
  • Measuring and Valuing Outcomes

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

PROMS_unsplash_National Cancer Institute_landscape
Read more
© NCI/Unsplash
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • Past Event

OHE Lunchtime Seminar: Economic Evaluation for Decision-Making and the Value of Access to Individual Patient Data

The international debate surrounding the opportunities offered by (and the challenges associated with) a more systematic approach to patient-level data sharing has yet to settle. The arguments in favour and against are well known, and the discussion so far has…

Date

27/03/23 10:33 am

The international debate surrounding the opportunities offered by (and the challenges associated with) a more systematic approach to patient-level data sharing has yet to settle. The arguments in favour and against are well known, and the discussion so far has involved a wide range of stakeholders with potentially competing interests.

To successfully support healthcare decision-making, cost-effectiveness analysis (CEA) must consider and synthesise all (relevant) available evidence relating to the clinical effectiveness, health-related quality of life (HRQoL) and costs of the health technologies under scrutiny.  The evidence base available to the HTA agency is often multifaceted and fragmented, comprising a mix of aggregate (or summary level data – AD) and individual patient-level data (IPD).  This poses a series of methodological issues for those tasked with providing information to support policy making. 

This lecture will offer a health economics perspective on the value of access to individual patient-level data (IPD) to guide HTA-like and other forms of decision-making in healthcare. 

Professor Andrea Manca’s research focuses on developing methodological solutions to address the issues faced by policy makers when trying to analyse and interpret health economics and outcome research data. This involves the use of statistical and decision modelling techniques for the analysis of cost effectiveness data. He has 17 years experience in applied health economics research and policy and has evaluated a wide range of health technologies (therapeutic medical devices, drugs, diagnostics and non pharmaceutical interventions) in a number of different clinical areas.  He received the 2008 ISPOR Award for Excellence in Methodology in Pharmacoeconomics and Health Outcomes Research for his contributions to the analysis of multinational individual patient level cost effectiveness data literature.  He is member of the NICE Technology Appraisal Committee, Deputy Chair of the UK National Institute of Health Research (NIHR) Doctoral Research Fellowships panel, and member of the ISPOR Bernie O’Brien New Investigator Award panel.  

To register for this event please click here.

 

Related Events

ValueofVacc_JoinedImage
  • Past Event
  • OHE Webinar
  • January 2023

The Value of Vaccines and Taskforces

Read more
Vaccines,Lockdowns Webinar
  • Past Event
  • OHE Webinar
  • January 2023

Vaccines, Antivirals, Lockdowns and COVID: Lessons from the Pandemic

Read more
Insights2022-2023
  • Past Event
  • OHE Webinar
  • January 2023

Insights From 2022 and Emerging Issues in 2023

Read more
Annual Lecture
  • Past Event
  • October 2022

Universal Health Coverage: More Than Just Old Wine in a New Bottle?

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!